Tsai Chen Lung 4
4 · CapsoVision, Inc · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
CapsoVision (CV) Director Tsai Chen Lung Receives 4,045 RSU Award
What Happened
- Tsai Chen Lung, a director of CapsoVision, was granted 4,045 Restricted Stock Units (RSUs) on March 19, 2026. The RSUs were reported as acquired at $0.00 (a non-cash award/derivative grant). Each RSU represents a contingent right to receive one share of CapsoVision common stock upon vesting.
Key Details
- Transaction date and price: 2026-03-19; 4,045 RSUs @ $0.00 (derivative award).
- Shares owned after transaction: Not specified in this Form 4.
- Vesting/footnotes: RSUs vest 50% on June 30, 2026 and 50% on December 31, 2026, subject to continued board service (per filing footnotes).
- Timeliness: Form 4 filed 2026-03-23 (within the required two business days), so the filing is timely.
- No sale or exercise: This is an award (A code) of RSUs — no immediate sale or stock sale-triggering event reported.
Context
- RSU awards are a common form of director compensation and are contingent on continued service until vesting; they do not represent immediately tradable shares until vested and settled.
- Because this is a grant rather than a market purchase or sale, it should be viewed as compensation, not a direct market-confidence signal.
Insider Transaction Report
Form 4
Tsai Chen Lung
Director
Transactions
- Award
Restricted Stock Unit (RSU)
[F1][F2]2026-03-19+4,045→ 4,045 total→ Common Stock (4,045 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.
Signature
/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung|2026-03-23